Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178455249> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3178455249 endingPage "159" @default.
- W3178455249 startingPage "154" @default.
- W3178455249 abstract "Objective: The present study's objective is to conduct a comparative bioavailability study with a special emphasis on the test product's bioequivalence using a standard reference product as a comparator.
 Methods: Before initiating the bioequivalent study, the plasma sample analysis method was developed and validated by using LC-MS/MS method. The entire study was conducted as a single-dose crossover randomized bioequivalence study with open-label, two treatment, two-period, and two sequences on 24 healthy volunteers under fasting condition. With proper informed consent process the oral dose of the Reference product (R) or Test product (T) was administered on healthy volunteers at 0 h during each period of the study. After the drug's oral administration, a certain quantity of blood sample was collected, and the plasma sample was separated using a cold centrifuge. The plasma samples were analysed by using the validated LC-MS/MS method. The pharmacokinetic parameters, statistical data and ANOVA of the test and reference product were evaluated.
 Results: The Cmax, Auc0-t, AUC0-∞ and tmax of the test product were found to be 6.29 ng/ml, 117.0 ng. h/ml, 161.67 ng. h/ml and 3.33 h. respectively. And the Cmax, Auc0-t, AUC0-∞ and tmax of reference product were found 6.59 ng/ml, 123.21 ng. h./ml, 172.20 ng. h/ml and 3.38 h respectively. Relative bioavailability was found 94.96%. The overall results show that the 90% confidence intervals (Log-Transformed and Untransformed) for Cmax, AUC0-t and AUC0-∞ for Azelnidipine were within the acceptable limit of 80%-125%.
 Conclusion: The entire study's conclusion can be drawn as the test product was bioequivalent with the reference product's comparator." @default.
- W3178455249 created "2021-07-19" @default.
- W3178455249 creator A5014037607 @default.
- W3178455249 creator A5015609305 @default.
- W3178455249 creator A5024740207 @default.
- W3178455249 creator A5029384299 @default.
- W3178455249 creator A5057530184 @default.
- W3178455249 creator A5067238201 @default.
- W3178455249 date "2021-07-07" @default.
- W3178455249 modified "2023-10-16" @default.
- W3178455249 title "BIOEQUIVALENCE STUDY OF AZELNIDIPINE 16 MG TABLET TO EVALUATE PHARMACOKINETIC PROFILE OF SINGLE DOSE IN HEALTHY, ADULT, HUMAN VOLUNTEERS UNDER FASTING CONDITION" @default.
- W3178455249 doi "https://doi.org/10.22159/ijap.2021v13i4.41331" @default.
- W3178455249 hasPublicationYear "2021" @default.
- W3178455249 type Work @default.
- W3178455249 sameAs 3178455249 @default.
- W3178455249 citedByCount "5" @default.
- W3178455249 countsByYear W31784552492022 @default.
- W3178455249 countsByYear W31784552492023 @default.
- W3178455249 crossrefType "journal-article" @default.
- W3178455249 hasAuthorship W3178455249A5014037607 @default.
- W3178455249 hasAuthorship W3178455249A5015609305 @default.
- W3178455249 hasAuthorship W3178455249A5024740207 @default.
- W3178455249 hasAuthorship W3178455249A5029384299 @default.
- W3178455249 hasAuthorship W3178455249A5057530184 @default.
- W3178455249 hasAuthorship W3178455249A5067238201 @default.
- W3178455249 hasBestOaLocation W31784552491 @default.
- W3178455249 hasConcept C112705442 @default.
- W3178455249 hasConcept C126322002 @default.
- W3178455249 hasConcept C142724271 @default.
- W3178455249 hasConcept C181389837 @default.
- W3178455249 hasConcept C185592680 @default.
- W3178455249 hasConcept C204787440 @default.
- W3178455249 hasConcept C22979827 @default.
- W3178455249 hasConcept C27081682 @default.
- W3178455249 hasConcept C42404028 @default.
- W3178455249 hasConcept C43617362 @default.
- W3178455249 hasConcept C44249647 @default.
- W3178455249 hasConcept C71924100 @default.
- W3178455249 hasConcept C87813604 @default.
- W3178455249 hasConcept C98274493 @default.
- W3178455249 hasConceptScore W3178455249C112705442 @default.
- W3178455249 hasConceptScore W3178455249C126322002 @default.
- W3178455249 hasConceptScore W3178455249C142724271 @default.
- W3178455249 hasConceptScore W3178455249C181389837 @default.
- W3178455249 hasConceptScore W3178455249C185592680 @default.
- W3178455249 hasConceptScore W3178455249C204787440 @default.
- W3178455249 hasConceptScore W3178455249C22979827 @default.
- W3178455249 hasConceptScore W3178455249C27081682 @default.
- W3178455249 hasConceptScore W3178455249C42404028 @default.
- W3178455249 hasConceptScore W3178455249C43617362 @default.
- W3178455249 hasConceptScore W3178455249C44249647 @default.
- W3178455249 hasConceptScore W3178455249C71924100 @default.
- W3178455249 hasConceptScore W3178455249C87813604 @default.
- W3178455249 hasConceptScore W3178455249C98274493 @default.
- W3178455249 hasLocation W31784552491 @default.
- W3178455249 hasOpenAccess W3178455249 @default.
- W3178455249 hasPrimaryLocation W31784552491 @default.
- W3178455249 hasRelatedWork W2349338867 @default.
- W3178455249 hasRelatedWork W2351830309 @default.
- W3178455249 hasRelatedWork W2353450705 @default.
- W3178455249 hasRelatedWork W2356698425 @default.
- W3178455249 hasRelatedWork W2357220270 @default.
- W3178455249 hasRelatedWork W2374069256 @default.
- W3178455249 hasRelatedWork W2387133671 @default.
- W3178455249 hasRelatedWork W2387566090 @default.
- W3178455249 hasRelatedWork W2392383498 @default.
- W3178455249 hasRelatedWork W48952282 @default.
- W3178455249 isParatext "false" @default.
- W3178455249 isRetracted "false" @default.
- W3178455249 magId "3178455249" @default.
- W3178455249 workType "article" @default.